ALTSHULER DAVID sold VRTX

March 10, 2025 · Form 4 insider transaction

ALTSHULER DAVID sold 3,231 shares of Vertex Pharmaceuticals Incorporated at $500.00 per share, a transaction worth $1.62M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,231
Price
$500.00
Total value
$1.62M
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after26,512
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.

View the original Form 4 on SEC EDGAR